US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

iHuman

2.97

+0.02000.68%

Volume:2.24K

Turnover:6.72K

Market Cap:153.02M

PE:11.34

High:3.00

Open:3.00

Low:2.97

Close:2.95

52wk High:3.60

52wk Low:1.47

Shares:51.52M

Float Shares:14.72M

Volume Ratio:0.86

T/O Rate:0.02%

Dividend:0.00

Dividend Rate:0.03%

EPS(TTM):0.2619

EPS(LYR):0.2578

ROE:11.26%

ROA:3.46%

PB:1.15

PE(LYR):11.52

Loading ...

Overview Company News Filings

Stock Index Futures Rally Across the Board as Discount Convergence Signals Market Optimism

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Stock Track | iHuman (IH) Soars 5.04% on Strong Q1 Results and Expanded Educational Offerings

iHuman Q1 Adj. EPS $0.07 Up From $0.06 YoY, Sales $28.999M Down From $32.548M YoY

BRIEF-Ihuman Q1 Revenue RMB 210.4 MLN

iHuman Inc. Reports Q1 2025 Revenue Decline to RMB210.4 Million, Net Income Rises to RMB26.5 Million

Press Release: Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Press Release: Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Press Release: Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Press Release: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Stock Track | iHuman Stock Plummets 5.79% Following Disappointing Q4 and Full Year 2024 Results

Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline

Press Release: iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IH\",,,,,undefined,":{"symbol":"IH","market":"US","secType":"STK","nameCN":"iHuman","latestPrice":2.97,"timestamp":1758119029503,"preClose":2.95,"halted":0,"volume":2244,"delay":0,"floatShares":14721579,"shares":51521578,"eps":0.261898,"marketStatus":"Trading","change":0.02,"latestTime":"09-17 10:24:42 EDT","open":3,"high":3,"low":2.97,"amount":6716.1380616,"amplitude":0.010169,"askPrice":3.23,"askSize":200,"bidPrice":2.97,"bidSize":44,"shortable":3,"etf":0,"ttmEps":0.261898,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1758139200000},"marketStatusCode":2,"adr":0,"adrRate":5,"listingDate":1602216000000,"exchange":"NYSE","adjPreClose":2.95,"dividendRate":0.000337,"preHourTrading":{"tag":"盘前","latestPrice":3.04,"preClose":2.95,"latestTime":"09:01 EDT","volume":51,"amount":150.5400048,"timestamp":1758114065731},"postHourTrading":{"tag":"盘后","latestPrice":3.06,"preClose":2.95,"latestTime":"18:53 EDT","volume":236,"amount":718.79,"timestamp":1758063232044},"volumeRatio":0.862037},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IH\",,,,,undefined,":{"symbol":"IH","floatShares":14721579,"roa":"3.46%","roe":"11.26%","lyrEps":0.257765,"volumeRatio":0.862037,"shares":51521578,"dividePrice":0.001,"high":3,"amplitude":0.010169,"preClose":2.95,"low":2.97,"week52Low":1.47,"pbRate":"1.15","psRate":"1.21","week52High":3.6,"institutionHeld":0,"latestPrice":2.97,"committee":-0.639344,"eps":0.261898,"divideRate":0.000337,"volume":2244,"delay":0,"ttmEps":0.261898,"open":3,"prevYearClose":1.69,"prevWeekClose":2.86,"prevMonthClose":2.795,"prevQuarterClose":2.5,"fiveDayClose":2.91,"twentyDayClose":2.7,"sixtyDayClose":2.3728},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-26","symbol":"IH","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1750910400000,"reportTimeType":"pre","actualEps":0.07},{"date":"2025-04-17","symbol":"IH","amount":0.1,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-17","defaultRemindTime":1744896600000,"name":"洪恩","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-04-17","currency":"USD","dateTimestamp":1744862400000,"payDate":"2025-05-15"},{"market":"US","date":"2025-03-25","symbol":"IH","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-12-26","symbol":"IH","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1735189200000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-09-27","symbol":"IH","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1727409600000,"reportTimeType":"pre","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IH\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-27","recordDate":"2024-03-28","paymentDate":"2024-05-15","value":0.1,"currency":"USD"},{"executeDate":"2025-04-17","recordDate":"2025-04-17","paymentDate":"2025-05-15","value":0.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IH","date":"2025-09-16","current":10.874442,"percent":0.827842,"low":-133.902359,"twenty":-29.207499,"median":5.067949,"eighty":10.376926,"high":5530.113888,"avg":159.679694,"sd":755.463905,"marketCap":157140812},"quantilePoints":[{"date":"2020-10-09","current":3015.153489,"twenty":2293.787118,"median":2293.827654,"eighty":2726.623155,"marketCap":836391616},{"date":"2020-10-16","current":4671.672124,"twenty":2582.357988,"median":4320.874306,"eighty":4827.609099,"marketCap":1295361515},{"date":"2020-10-23","current":3576.429918,"twenty":3054.346825,"median":3950.507078,"eighty":4590.121793,"marketCap":993215044},{"date":"2020-10-30","current":3382.234713,"twenty":3220.775982,"median":3568.61436,"eighty":4432.812866,"marketCap":938849588},{"date":"2020-11-06","current":4034.939846,"twenty":3394.42959,"median":3740.899882,"eighty":4332.766989,"marketCap":1133310639},{"date":"2020-11-13","current":4488.973537,"twenty":3422.358528,"median":3821.187811,"eighty":4445.304782,"marketCap":1261905850},{"date":"2020-11-20","current":4767.084272,"twenty":3466.034133,"median":3950.507078,"eighty":4477.549968,"marketCap":1348681480},{"date":"2020-11-27","current":5353.033215,"twenty":3519.796499,"median":4037.558213,"eighty":4638.086879,"marketCap":1511255101},{"date":"2020-12-04","current":804.947539,"twenty":3417.540217,"median":4036.249029,"eighty":4748.001842,"marketCap":1214336077},{"date":"2020-12-11","current":790.928981,"twenty":2438.092821,"median":3871.756867,"eighty":4638.086879,"marketCap":1190289818},{"date":"2020-12-18","current":773.47919,"twenty":839.797655,"median":3809.879703,"eighty":4500.791427,"marketCap":1165720814},{"date":"2020-12-24","current":703.755238,"twenty":804.795355,"median":3658.6649,"eighty":4488.973537,"marketCap":1061694607},{"date":"2020-12-31","current":627.687586,"twenty":782.034363,"median":3560.160364,"eighty":4485.036639,"marketCap":947213505},{"date":"2021-01-08","current":693.040329,"twenty":735.871662,"median":3436.813461,"eighty":4471.047521,"marketCap":1054898925},{"date":"2021-01-15","current":631.925226,"twenty":705.894649,"median":3247.685771,"eighty":4422.813267,"marketCap":960804868},{"date":"2021-01-22","current":785.483217,"twenty":699.469274,"median":2654.490571,"eighty":4392.829635,"marketCap":1193949031},{"date":"2021-01-29","current":629.066628,"twenty":676.404566,"median":880.984684,"eighty":4370.542391,"marketCap":963941337},{"date":"2021-02-05","current":656.411833,"twenty":657.588495,"median":826.141001,"eighty":4316.280848,"marketCap":1000010725},{"date":"2021-02-12","current":731.808279,"twenty":655.410123,"median":804.795355,"eighty":4271.81883,"marketCap":1116582807},{"date":"2021-02-19","current":677.913997,"twenty":656.651329,"median":790.928981,"eighty":4262.599202,"marketCap":1034511880},{"date":"2021-02-26","current":635.403102,"twenty":651.117511,"median":778.826173,"eighty":4171.869822,"marketCap":967077806},{"date":"2021-03-05","current":520.076355,"twenty":646.138503,"median":752.847189,"eighty":4036.510866,"marketCap":788821842},{"date":"2021-03-12","current":549.771961,"twenty":636.290266,"median":736.659373,"eighty":4001.166739,"marketCap":832209657},{"date":"2021-03-19","current":530.498446,"twenty":628.593395,"median":733.320641,"eighty":3919.006994,"marketCap":802935951},{"date":"2021-03-26","current":-119.142665,"twenty":622.879828,"median":723.261143,"eighty":3852.888927,"marketCap":682553292},{"date":"2021-04-01","current":-125.368105,"twenty":614.667992,"median":707.536529,"eighty":3823.227334,"marketCap":715614467},{"date":"2021-04-09","current":-113.562337,"twenty":565.399136,"median":703.755238,"eighty":3814.625044,"marketCap":649492117},{"date":"2021-04-16","current":-112.545567,"twenty":523.879982,"median":686.74313,"eighty":3789.756617,"marketCap":646825893},{"date":"2021-04-23","current":-111.847122,"twenty":514.239421,"median":677.913997,"eighty":3708.005889,"marketCap":645226159},{"date":"2021-04-30","current":-117.931495,"twenty":499.145216,"median":663.056135,"eighty":3573.303695,"marketCap":682553292},{"date":"2021-05-07","current":-104.444617,"twenty":-103.746008,"median":657.010573,"eighty":3560.543427,"marketCap":608432271},{"date":"2021-05-14","current":-87.930916,"twenty":-104.32854,"median":653.509616,"eighty":3549.590569,"marketCap":511914969},{"date":"2021-05-21","current":-93.108401,"twenty":-103.746008,"median":650.811921,"eighty":3495.254806,"marketCap":542309920},{"date":"2021-05-28","current":-81.191712,"twenty":-102.442665,"median":647.009022,"eighty":3431.99515,"marketCap":477787304},{"date":"2021-06-04","current":-87.354472,"twenty":-99.120858,"median":643.585878,"eighty":3412.721906,"marketCap":511914969},{"date":"2021-06-11","current":-121.506119,"twenty":-104.444617,"median":637.621013,"eighty":3382.234713,"marketCap":546042634},{"date":"2021-06-18","current":-123.977073,"twenty":-107.5859,"median":632.756179,"eighty":3113.136829,"marketCap":552441571},{"date":"2021-06-25","current":-117.92327,"twenty":-112.451914,"median":628.277906,"eighty":3015.153489,"marketCap":525246088},{"date":"2021-07-02","current":-123.136182,"twenty":-113.47692,"median":626.857752,"eighty":2293.827654,"marketCap":547109123},{"date":"2021-07-09","current":-125.077341,"twenty":-115.016946,"median":620.420958,"eighty":2293.773606,"marketCap":555107795},{"date":"2021-07-16","current":-121.713107,"twenty":-116.058,"median":613.655707,"eighty":1163.539766,"marketCap":540176941},{"date":"2021-07-23","current":-99.159878,"twenty":-116.704465,"median":606.466795,"eighty":850.313746,"marketCap":439926927},{"date":"2021-07-30","current":-81.962671,"twenty":-116.462081,"median":549.771961,"eighty":839.797655,"marketCap":364739415},{"date":"2021-08-06","current":-95.574708,"twenty":-116.394969,"median":526.361906,"eighty":818.374262,"marketCap":423929584},{"date":"2021-08-13","current":-89.247497,"twenty":-116.058,"median":520.076355,"eighty":806.597318,"marketCap":396200856},{"date":"2021-08-20","current":-79.694483,"twenty":-115.969453,"median":511.361225,"eighty":804.825792,"marketCap":352474786},{"date":"2021-08-27","current":-80.770614,"twenty":-115.609201,"median":502.73304,"eighty":795.69142,"marketCap":358873723},{"date":"2021-09-03","current":-79.12817,"twenty":-115.349844,"median":477.975024,"eighty":791.426272,"marketCap":352474786},{"date":"2021-09-10","current":-80.336523,"twenty":-115.089567,"median":-73.530136,"eighty":787.661523,"marketCap":358473789},{"date":"2021-09-17","current":-67.147557,"twenty":-114.328592,"median":-74.614002,"eighty":784.69718,"marketCap":298617065},{"date":"2021-09-24","current":-58.274486,"twenty":-113.704643,"median":-64.467994,"eighty":777.756776,"marketCap":259156953},{"date":"2021-10-01","current":-49.547641,"twenty":-113.511087,"median":-59.474475,"eighty":764.975361,"marketCap":261823177},{"date":"2021-10-08","current":-49.124934,"twenty":-113.402575,"median":-57.951772,"eighty":755.43077,"marketCap":259690198},{"date":"2021-10-15","current":-50.869488,"twenty":-112.875794,"median":-56.415625,"eighty":744.882323,"marketCap":269288603},{"date":"2021-10-22","current":-50.973165,"twenty":-112.5504,"median":-52.468224,"eighty":738.049419,"marketCap":271954827},{"date":"2021-10-29","current":-50.136495,"twenty":-112.489375,"median":-51.782478,"eighty":736.58443,"marketCap":266622380},{"date":"2021-11-05","current":-44.375169,"twenty":-112.089039,"median":-51.143684,"eighty":735.045674,"marketCap":236227428},{"date":"2021-11-12","current":-45.137305,"twenty":-111.53551,"median":-50.869488,"eighty":733.680259,"marketCap":241026631},{"date":"2021-11-19","current":-50.496354,"twenty":-111.004598,"median":-50.832123,"eighty":732.413224,"marketCap":269288603},{"date":"2021-11-26","current":-43.726266,"twenty":-109.507851,"median":-50.628452,"eighty":731.375604,"marketCap":233027960},{"date":"2021-12-03","current":-37.630589,"twenty":-107.079206,"median":-50.257918,"eighty":724.754232,"marketCap":201033274},{"date":"2021-12-10","current":-34.397058,"twenty":-106.044558,"median":-49.787164,"eighty":712.934839,"marketCap":183969442},{"date":"2021-12-17","current":-26.848373,"twenty":-105.424198,"median":-49.547641,"eighty":707.757935,"marketCap":143442840},{"date":"2021-12-23","current":-12.376015,"twenty":-104.978143,"median":-49.124934,"eighty":706.263236,"marketCap":161039917},{"date":"2021-12-31","current":-11.44257,"twenty":-104.32854,"median":-48.296909,"eighty":705.229584,"marketCap":149308532},{"date":"2022-01-07","current":-12.225705,"twenty":-103.746008,"median":-47.398103,"eighty":701.612256,"marketCap":158906938},{"date":"2022-01-14","current":-11.810924,"twenty":-102.450469,"median":-47.2735,"eighty":692.642017,"marketCap":154107735},{"date":"2022-01-21","current":-10.84717,"twenty":-99.159878,"median":-47.015709,"eighty":691.048767,"marketCap":141843106},{"date":"2022-01-28","current":-10.189171,"twenty":-99.120858,"median":-46.619249,"eighty":682.437492,"marketCap":132777945},{"date":"2022-02-04","current":-10.884816,"twenty":-97.125779,"median":-45.583194,"eighty":680.230928,"marketCap":141843106},{"date":"2022-02-11","current":-11.039292,"twenty":-96.220313,"median":-44.375169,"eighty":677.913997,"marketCap":143976085},{"date":"2022-02-18","current":-8.79016,"twenty":-95.574708,"median":-42.210885,"eighty":667.355176,"marketCap":115180868},{"date":"2022-02-25","current":-8.98141,"twenty":-95.510693,"median":-40.959026,"eighty":667.269098,"marketCap":117847091},{"date":"2022-03-04","current":-8.251982,"twenty":-95.20451,"median":-38.926977,"eighty":660.54127,"marketCap":108248686},{"date":"2022-03-11","current":-7.462995,"twenty":-94.808956,"median":-36.013824,"eighty":658.471288,"marketCap":97583791},{"date":"2022-03-18","current":-8.920915,"twenty":-94.676063,"median":-28.19119,"eighty":657.283046,"marketCap":116247357},{"date":"2022-03-25","current":-18.866826,"twenty":-93.419326,"median":-26.998296,"eighty":656.531581,"marketCap":109819592},{"date":"2022-04-01","current":-19.328292,"twenty":-92.356265,"median":-26.514801,"eighty":654.408413,"marketCap":112551689},{"date":"2022-04-08","current":-21.530715,"twenty":-91.682092,"median":-22.02776,"eighty":653.270851,"marketCap":125355047},{"date":"2022-04-14","current":-24.987257,"twenty":-91.447105,"median":-22.037435,"eighty":652.190207,"marketCap":145176144},{"date":"2022-04-22","current":-27.260737,"twenty":-90.097086,"median":-24.216161,"eighty":651.117511,"marketCap":155354545},{"date":"2022-04-29","current":-28.659399,"twenty":-89.238537,"median":-24.921245,"eighty":650.361632,"marketCap":160680849},{"date":"2022-05-06","current":-27.853548,"twenty":-89.112489,"median":-26.439373,"eighty":648.4806,"marketCap":154808791},{"date":"2022-05-13","current":-27.970843,"twenty":-88.563647,"median":-26.73268,"eighty":646.925485,"marketCap":152673498},{"date":"2022-05-20","current":-23.721773,"twenty":-88.058997,"median":-26.616987,"eighty":646.138503,"marketCap":131320561},{"date":"2022-05-27","current":-23.165322,"twenty":-87.724963,"median":-25.883101,"eighty":643.13573,"marketCap":128117620},{"date":"2022-06-03","current":-26.293113,"twenty":-87.494385,"median":-25.157043,"eighty":640.578044,"marketCap":146267617},{"date":"2022-06-10","current":-25.614648,"twenty":-87.306729,"median":-25.614648,"eighty":638.713845,"marketCap":141463206},{"date":"2022-06-17","current":-23.612227,"twenty":-86.817126,"median":-25.605519,"eighty":636.733849,"marketCap":130252914},{"date":"2022-06-24","current":-27.115854,"twenty":-86.136049,"median":-26.077753,"eighty":635.039908,"marketCap":125982327},{"date":"2022-07-01","current":-28.429368,"twenty":-85.885175,"median":-26.439373,"eighty":633.25475,"marketCap":131854384},{"date":"2022-07-08","current":-30.351577,"twenty":-85.747192,"median":-26.616987,"eighty":631.925226,"marketCap":140929382},{"date":"2022-07-15","current":-29.596306,"twenty":-85.614879,"median":-26.666795,"eighty":629.066628,"marketCap":136124972},{"date":"2022-07-22","current":-27.948235,"twenty":-84.864678,"median":-26.848373,"eighty":628.277906,"marketCap":128651444},{"date":"2022-07-29","current":-27.223763,"twenty":-84.560068,"median":-27.09995,"eighty":627.834765,"marketCap":125448503},{"date":"2022-08-05","current":-26.480595,"twenty":-84.530822,"median":-27.115854,"eighty":627.687586,"marketCap":121711739},{"date":"2022-08-12","current":-23.394954,"twenty":-84.184678,"median":-26.846386,"eighty":626.027918,"marketCap":107832330},{"date":"2022-08-19","current":-23.889037,"twenty":-84.005845,"median":-26.6608,"eighty":620.781101,"marketCap":108899977},{"date":"2022-08-26","current":-25.849463,"twenty":-83.715646,"median":-26.586015,"eighty":620.060815,"marketCap":116907328},{"date":"2022-09-02","current":-23.702662,"twenty":-83.660932,"median":-26.480595,"eighty":618.717133,"marketCap":106764684},{"date":"2022-09-09","current":-23.434761,"twenty":-83.338257,"median":-26.293113,"eighty":614.667992,"marketCap":105163213},{"date":"2022-09-16","current":-23.895191,"twenty":-83.187166,"median":-26.002194,"eighty":612.737131,"marketCap":106230860},{"date":"2022-09-23","current":-64.42075,"twenty":-83.126247,"median":-25.981013,"eighty":610.764129,"marketCap":101188968},{"date":"2022-09-30","current":-74.451171,"twenty":-82.37477,"median":-26.212622,"eighty":604.149898,"marketCap":117166174},{"date":"2022-10-07","current":-65.317656,"twenty":-82.044955,"median":-26.480595,"eighty":565.399136,"marketCap":102786689},{"date":"2022-10-14","current":-65.33401,"twenty":-81.971895,"median":-26.586015,"eighty":551.037088,"marketCap":101721542},{"date":"2022-10-21","current":-65.094013,"twenty":-81.820527,"median":-26.6608,"eighty":536.538185,"marketCap":100656395},{"date":"2022-10-28","current":-56.233875,"twenty":-81.757557,"median":-26.846386,"eighty":531.044705,"marketCap":86809483},{"date":"2022-11-04","current":-68.679106,"twenty":-81.439956,"median":-27.115854,"eighty":523.879982,"marketCap":107047277},{"date":"2022-11-11","current":-57.472225,"twenty":-81.334594,"median":-27.190076,"eighty":521.320286,"marketCap":90537498},{"date":"2022-11-18","current":-73.830342,"twenty":-81.266321,"median":-27.322252,"eighty":520.279887,"marketCap":116101027},{"date":"2022-11-25","current":-69.24178,"twenty":-81.21542,"median":-27.372342,"eighty":518.547538,"marketCap":108112424},{"date":"2022-12-02","current":-70.787846,"twenty":-81.038495,"median":-27.470153,"eighty":515.061647,"marketCap":112905586},{"date":"2022-12-09","current":11.251796,"twenty":-80.836909,"median":-27.518685,"eighty":510.950031,"marketCap":107524840},{"date":"2022-12-16","current":12.895086,"twenty":-80.510159,"median":-27.382731,"eighty":506.132555,"marketCap":122961574},{"date":"2022-12-23","current":13.931198,"twenty":-80.01649,"median":-27.322252,"eighty":503.246793,"marketCap":132542996},{"date":"2022-12-30","current":14.359267,"twenty":-79.759674,"median":-27.223763,"eighty":500.939128,"marketCap":138398309},{"date":"2023-01-06","current":21.077172,"twenty":-79.597373,"median":-27.148219,"eighty":494.557622,"marketCap":204935958},{"date":"2023-01-13","current":20.255524,"twenty":-79.192781,"median":-26.966209,"eighty":479.067051,"marketCap":200677548},{"date":"2023-01-20","current":20.474685,"twenty":-79.12817,"median":-26.758595,"eighty":476.154977,"marketCap":200677548},{"date":"2023-01-27","current":20.531717,"twenty":-77.967048,"median":-26.619311,"eighty":21.589051,"marketCap":201209849},{"date":"2023-02-03","current":15.648931,"twenty":-77.398452,"median":-26.534921,"eighty":21.077172,"marketCap":153835043},{"date":"2023-02-10","current":14.716537,"twenty":-76.140032,"median":-26.439373,"eighty":20.611136,"marketCap":143721321},{"date":"2023-02-17","current":15.672184,"twenty":-75.039113,"median":-26.077753,"eighty":20.531717,"marketCap":151705839},{"date":"2023-02-24","current":17.712209,"twenty":-74.699024,"median":-25.970433,"eighty":20.486091,"marketCap":169271778},{"date":"2023-03-03","current":20.018891,"twenty":-74.560532,"median":-25.736073,"eighty":20.419914,"marketCap":192693030},{"date":"2023-03-10","current":18.127093,"twenty":-74.47037,"median":-25.472181,"eighty":20.285663,"marketCap":174062489},{"date":"2023-03-17","current":16.872549,"twenty":-73.954508,"median":-25.301422,"eighty":20.253874,"marketCap":162884164},{"date":"2023-03-24","current":16.222086,"twenty":-72.382996,"median":-24.886301,"eighty":20.065805,"marketCap":157028851},{"date":"2023-03-31","current":10.787756,"twenty":-71.3665,"median":-24.752338,"eighty":20.013517,"marketCap":172465585},{"date":"2023-04-06","current":10.614379,"twenty":-71.119552,"median":-24.651893,"eighty":20.01091,"marketCap":169530932},{"date":"2023-04-14","current":10.897737,"twenty":-70.89832,"median":-24.529866,"eighty":19.995566,"marketCap":174228905},{"date":"2023-04-21","current":10.642547,"twenty":-70.662676,"median":-24.344147,"eighty":19.981604,"marketCap":170062377},{"date":"2023-04-28","current":10.261973,"twenty":-70.26897,"median":-24.087287,"eighty":19.726204,"marketCap":162759014},{"date":"2023-05-05","current":10.375731,"twenty":-69.896663,"median":-23.989384,"eighty":19.345672,"marketCap":164872768},{"date":"2023-05-12","current":10.699055,"twenty":-69.754458,"median":-23.895191,"eighty":19.258934,"marketCap":169100275},{"date":"2023-05-19","current":12.738201,"twenty":-69.647672,"median":-23.817492,"eighty":19.138658,"marketCap":198692823},{"date":"2023-05-26","current":10.145318,"twenty":-69.486863,"median":-23.706814,"eighty":19.049996,"marketCap":157474631},{"date":"2023-06-02","current":8.912544,"twenty":-69.309827,"median":-23.66934,"eighty":18.925288,"marketCap":137922411},{"date":"2023-06-09","current":9.478231,"twenty":-69.195614,"median":-23.578708,"eighty":18.8846,"marketCap":146377425},{"date":"2023-06-16","current":9.95334,"twenty":-68.977174,"median":-23.434761,"eighty":18.784254,"marketCap":153247124},{"date":"2023-06-23","current":7.317993,"twenty":-68.842076,"median":-23.332567,"eighty":18.682471,"marketCap":153247124},{"date":"2023-06-30","current":7.621083,"twenty":-68.7117,"median":-23.313042,"eighty":18.595573,"marketCap":158003069},{"date":"2023-07-07","current":7.569581,"twenty":-68.57814,"median":-23.165322,"eighty":18.516354,"marketCap":156946192},{"date":"2023-07-14","current":7.74125,"twenty":-68.360527,"median":-23.084847,"eighty":18.357204,"marketCap":162759014},{"date":"2023-07-21","current":7.415726,"twenty":-68.154458,"median":-22.784028,"eighty":18.262726,"marketCap":155360877},{"date":"2023-07-28","current":7.58943,"twenty":-67.928832,"median":-22.552521,"eighty":18.177631,"marketCap":159059946},{"date":"2023-08-04","current":8.538508,"twenty":-67.786772,"median":-22.067165,"eighty":18.036212,"marketCap":179140604},{"date":"2023-08-11","current":8.599752,"twenty":-67.392925,"median":-21.761057,"eighty":17.926251,"marketCap":179140604},{"date":"2023-08-18","current":8.200541,"twenty":-67.098258,"median":-21.082907,"eighty":17.784659,"marketCap":169100275},{"date":"2023-08-25","current":7.609195,"twenty":-67.057337,"median":-19.928268,"eighty":17.708857,"marketCap":157210412},{"date":"2023-09-01","current":7.245142,"twenty":-67.046398,"median":-19.328292,"eighty":17.625182,"marketCap":150076494},{"date":"2023-09-08","current":8.165334,"twenty":-66.784088,"median":-18.866826,"eighty":17.482007,"marketCap":167514960},{"date":"2023-09-15","current":7.87776,"twenty":-66.329394,"median":-12.52392,"eighty":17.258673,"marketCap":162759014},{"date":"2023-09-22","current":6.744063,"twenty":-66.219838,"median":-12.376015,"eighty":17.023211,"marketCap":157474631},{"date":"2023-09-29","current":6.570956,"twenty":-66.144779,"median":-12.298084,"eighty":16.797331,"marketCap":153565006},{"date":"2023-10-06","current":6.632418,"twenty":-65.908841,"median":-12.175509,"eighty":16.676727,"marketCap":155005668},{"date":"2023-10-12","current":6.434946,"twenty":-65.651474,"median":-11.881642,"eighty":16.655339,"marketCap":150398718},{"date":"2023-10-20","current":5.972544,"twenty":-65.488282,"median":-11.523642,"eighty":16.591901,"marketCap":139316707},{"date":"2023-10-27","current":5.860553,"twenty":-65.487919,"median":-11.464021,"eighty":16.54281,"marketCap":136678133},{"date":"2023-11-03","current":5.860233,"twenty":-65.478141,"median":-11.354541,"eighty":16.489434,"marketCap":136678133},{"date":"2023-11-10","current":5.965953,"twenty":-65.389152,"median":-11.135132,"eighty":16.41522,"marketCap":139770541},{"date":"2023-11-17","current":6.046997,"twenty":-65.324198,"median":-11.039292,"eighty":16.308917,"marketCap":142482996},{"date":"2023-11-24","current":5.635263,"twenty":-65.228199,"median":-10.915602,"eighty":16.260424,"marketCap":134567274},{"date":"2023-12-01","current":6.069161,"twenty":-64.910178,"median":-10.865993,"eighty":16.236684,"marketCap":145121570},{"date":"2023-12-08","current":5.778828,"twenty":-64.593491,"median":-10.516533,"eighty":16.211144,"marketCap":137997420},{"date":"2023-12-15","current":6.061528,"twenty":-64.487554,"median":-10.314987,"eighty":16.18531,"marketCap":145649284},{"date":"2023-12-22","current":6.073073,"twenty":-64.323712,"median":-10.189171,"eighty":16.139946,"marketCap":145121570},{"date":"2023-12-29","current":5.949859,"twenty":-64.178155,"median":-10.088679,"eighty":16.093099,"marketCap":153301149},{"date":"2024-01-05","current":5.805284,"twenty":-64.099823,"median":-9.94021,"eighty":16.022939,"marketCap":148726216},{"date":"2024-01-12","current":5.514377,"twenty":-63.618717,"median":-9.468635,"eighty":15.900232,"marketCap":141342645},{"date":"2024-01-19","current":6.115656,"twenty":-63.325946,"median":-9.196155,"eighty":15.818308,"marketCap":155582389},{"date":"2024-01-26","current":5.636805,"twenty":-63.196265,"median":-9.088655,"eighty":15.752752,"marketCap":144507032},{"date":"2024-02-02","current":4.964524,"twenty":-62.945888,"median":-8.877979,"eighty":15.703782,"marketCap":126575503},{"date":"2024-02-09","current":4.721345,"twenty":-62.418765,"median":-8.79016,"eighty":15.666016,"marketCap":120774125},{"date":"2024-02-16","current":4.852088,"twenty":-61.561414,"median":-8.645478,"eighty":15.653631,"marketCap":123938513},{"date":"2024-02-23","current":4.714409,"twenty":-61.165479,"median":-8.394602,"eighty":15.648455,"marketCap":119983029},{"date":"2024-03-01","current":4.204659,"twenty":-60.897027,"median":-8.293682,"eighty":15.644092,"marketCap":107061779},{"date":"2024-03-08","current":4.0195,"twenty":-60.462721,"median":-7.902436,"eighty":15.623894,"marketCap":101099140},{"date":"2024-03-15","current":4.08959,"twenty":-59.288225,"median":-7.109283,"eighty":15.559961,"marketCap":102844866},{"date":"2024-03-22","current":3.756903,"twenty":-58.489478,"median":-0.597309,"eighty":15.461807,"marketCap":94406313},{"date":"2024-03-28","current":3.581788,"twenty":-58.274486,"median":3.785359,"eighty":15.429213,"marketCap":89659626},{"date":"2024-04-05","current":3.754028,"twenty":-58.103317,"median":3.754028,"eighty":15.265664,"marketCap":93878903},{"date":"2024-04-12","current":3.93018,"twenty":-57.800228,"median":3.753613,"eighty":15.153111,"marketCap":98240580},{"date":"2024-04-19","current":3.619091,"twenty":-57.472225,"median":3.754028,"eighty":14.825454,"marketCap":90450741},{"date":"2024-04-26","current":3.696217,"twenty":-56.803966,"median":3.745618,"eighty":14.749615,"marketCap":92296674},{"date":"2024-05-03","current":3.672048,"twenty":-56.415625,"median":3.710255,"eighty":14.716537,"marketCap":91769265},{"date":"2024-05-10","current":3.572862,"twenty":-56.233875,"median":3.704611,"eighty":14.545739,"marketCap":89516801},{"date":"2024-05-17","current":3.992595,"twenty":-54.288637,"median":3.72302,"eighty":14.504524,"marketCap":100048189},{"date":"2024-05-24","current":4.215887,"twenty":-53.28149,"median":3.745854,"eighty":14.359267,"marketCap":105313884},{"date":"2024-05-31","current":4.173666,"twenty":-53.217826,"median":3.753613,"eighty":14.206804,"marketCap":104260745},{"date":"2024-06-07","current":4.228116,"twenty":-52.954726,"median":3.756363,"eighty":13.978696,"marketCap":105577168},{"date":"2024-06-14","current":4.263687,"twenty":-52.66213,"median":3.77762,"eighty":13.734399,"marketCap":106367022},{"date":"2024-06-21","current":3.909764,"twenty":-52.476232,"median":3.813814,"eighty":13.427207,"marketCap":97415342},{"date":"2024-06-28","current":3.956328,"twenty":-52.444201,"median":3.815294,"eighty":13.251214,"marketCap":98468481},{"date":"2024-07-05","current":4.428231,"twenty":-52.374063,"median":3.843672,"eighty":13.075932,"marketCap":91096509},{"date":"2024-07-12","current":4.292969,"twenty":-52.159314,"median":3.862231,"eighty":12.944148,"marketCap":88463662},{"date":"2024-07-15","current":4.188792,"twenty":-52.099759,"median":3.872037,"eighty":12.919617,"marketCap":86357384},{"date":"2024-08-02","current":4.079809,"twenty":-52.040203,"median":3.876302,"eighty":12.895086,"marketCap":84251107},{"date":"2024-08-09","current":4.016242,"twenty":-51.782478,"median":3.880567,"eighty":12.738201,"marketCap":83724537},{"date":"2024-08-16","current":3.990932,"twenty":-51.641514,"median":3.892399,"eighty":12.704329,"marketCap":83197968},{"date":"2024-08-23","current":4.075087,"twenty":-51.157034,"median":3.894801,"eighty":12.522599,"marketCap":85304246},{"date":"2024-08-30","current":3.898504,"twenty":-51.130333,"median":3.903824,"eighty":12.321334,"marketCap":82144829},{"date":"2024-09-06","current":3.870408,"twenty":-51.121558,"median":3.906794,"eighty":11.93542,"marketCap":81618260},{"date":"2024-09-13","current":3.859099,"twenty":-51.002405,"median":3.903824,"eighty":11.456534,"marketCap":81091690},{"date":"2024-09-20","current":3.9671,"twenty":-50.890223,"median":3.9082,"eighty":11.273623,"marketCap":83950962},{"date":"2024-09-27","current":4.319659,"twenty":-50.809704,"median":3.909764,"eighty":11.108562,"marketCap":92149648},{"date":"2024-10-04","current":5.879801,"twenty":-50.767392,"median":3.931399,"eighty":11.029879,"marketCap":110501873},{"date":"2024-10-11","current":5.499863,"twenty":-50.549193,"median":3.939908,"eighty":10.979463,"marketCap":102646289},{"date":"2024-10-18","current":5.214344,"twenty":-50.442871,"median":3.958702,"eighty":10.954849,"marketCap":96754602},{"date":"2024-10-25","current":5.219422,"twenty":-50.292234,"median":3.966788,"eighty":10.944012,"marketCap":96885528},{"date":"2024-10-31","current":5.105491,"twenty":-50.185064,"median":3.968042,"eighty":10.942007,"marketCap":94790706},{"date":"2024-11-08","current":5.167096,"twenty":-50.081411,"median":3.991764,"eighty":10.930004,"marketCap":95529131},{"date":"2024-11-15","current":4.672759,"twenty":-49.897475,"median":4.008147,"eighty":10.907481,"marketCap":85364006},{"date":"2024-11-22","current":4.440508,"twenty":-49.78473,"median":4.0271,"eighty":10.878829,"marketCap":81069620},{"date":"2024-11-29","current":4.736699,"twenty":-49.6958,"median":4.040143,"eighty":10.857926,"marketCap":86411417},{"date":"2024-12-06","current":4.689102,"twenty":-49.565261,"median":4.04993,"eighty":10.843894,"marketCap":85364006},{"date":"2024-12-13","current":4.838269,"twenty":-49.5214,"median":4.067482,"eighty":10.830193,"marketCap":87982534},{"date":"2024-12-20","current":5.089027,"twenty":-49.339197,"median":4.079809,"eighty":10.809498,"marketCap":92172178},{"date":"2024-12-27","current":6.383451,"twenty":-49.076179,"median":4.096351,"eighty":10.803058,"marketCap":92172178},{"date":"2025-01-03","current":6.149372,"twenty":-48.881161,"median":4.109295,"eighty":10.799568,"marketCap":88776402},{"date":"2025-01-10","current":6.013414,"twenty":-48.785915,"median":4.112845,"eighty":10.790662,"marketCap":86426438},{"date":"2025-01-17","current":6.249589,"twenty":-48.017792,"median":4.116582,"eighty":10.787892,"marketCap":89820830},{"date":"2025-01-24","current":5.959023,"twenty":-47.641921,"median":4.161776,"eighty":10.760214,"marketCap":86165331},{"date":"2025-01-31","current":6.018765,"twenty":-47.445019,"median":4.173666,"eighty":10.730465,"marketCap":87470866},{"date":"2025-02-07","current":6.284576,"twenty":-47.356742,"median":4.176545,"eighty":10.708582,"marketCap":90865258},{"date":"2025-02-14","current":6.707059,"twenty":-47.326502,"median":4.204659,"eighty":10.66515,"marketCap":96912498},{"date":"2025-02-21","current":6.723628,"twenty":-47.283745,"median":4.218352,"eighty":10.63128,"marketCap":97654042},{"date":"2025-02-28","current":7.467655,"twenty":-47.216733,"median":4.228962,"eighty":10.608026,"marketCap":108098324},{"date":"2025-03-07","current":7.685188,"twenty":-47.054251,"median":4.238658,"eighty":10.595139,"marketCap":111753823},{"date":"2025-03-14","current":9.29828,"twenty":-46.801402,"median":4.25916,"eighty":10.589398,"marketCap":135253459},{"date":"2025-03-21","current":9.805225,"twenty":-46.709104,"median":4.263687,"eighty":10.608026,"marketCap":142564457},{"date":"2025-03-28","current":9.162264,"twenty":-46.618583,"median":4.29309,"eighty":10.595139,"marketCap":124320249},{"date":"2025-04-04","current":8.29809,"twenty":-46.382185,"median":4.29859,"eighty":10.589398,"marketCap":112356376},{"date":"2025-04-11","current":7.023312,"twenty":-45.672372,"median":4.324447,"eighty":10.583231,"marketCap":94670650},{"date":"2025-04-17","current":7.471132,"twenty":-45.010945,"median":4.368261,"eighty":10.575507,"marketCap":100912671},{"date":"2025-04-25","current":7.998984,"twenty":-44.479436,"median":4.416873,"eighty":10.57296,"marketCap":108195029},{"date":"2025-05-02","current":8.670454,"twenty":-44.245388,"median":4.428871,"eighty":10.558707,"marketCap":117558060},{"date":"2025-05-09","current":8.915917,"twenty":-43.660115,"median":4.454541,"eighty":10.528838,"marketCap":121474204},{"date":"2025-05-16","current":8.588123,"twenty":-42.92166,"median":4.537999,"eighty":10.489211,"marketCap":117469197},{"date":"2025-05-23","current":8.660814,"twenty":-41.014936,"median":4.582439,"eighty":10.463758,"marketCap":118499629},{"date":"2025-05-30","current":8.82465,"twenty":-40.969642,"median":4.644091,"eighty":10.375731,"marketCap":121075708},{"date":"2025-06-06","current":8.771568,"twenty":-40.94841,"median":4.676947,"eighty":10.261973,"marketCap":120560492},{"date":"2025-06-13","current":8.996986,"twenty":-38.931461,"median":4.696264,"eighty":10.26149,"marketCap":123651787},{"date":"2025-06-20","current":8.677103,"twenty":-38.927874,"median":4.714409,"eighty":10.19962,"marketCap":119014845},{"date":"2025-06-27","current":8.262423,"twenty":-38.645259,"median":4.741128,"eighty":10.153085,"marketCap":118504781},{"date":"2025-07-03","current":8.980257,"twenty":-38.008285,"median":4.762353,"eighty":10.095367,"marketCap":128803945},{"date":"2025-07-11","current":7.995059,"twenty":-35.69047,"median":4.821514,"eighty":10.054824,"marketCap":114558228},{"date":"2025-07-18","current":10.937357,"twenty":-34.125417,"median":4.837071,"eighty":10.054824,"marketCap":156625597},{"date":"2025-07-25","current":10.82817,"twenty":-31.788675,"median":4.866399,"eighty":10.215088,"marketCap":155595165},{"date":"2025-08-01","current":10.823366,"twenty":-30.034514,"median":4.8717,"eighty":10.419745,"marketCap":154564734},{"date":"2025-08-08","current":10.076407,"twenty":-29.78409,"median":4.911136,"eighty":10.487488,"marketCap":144260418},{"date":"2025-08-15","current":9.891234,"twenty":-29.741558,"median":4.947941,"eighty":10.419745,"marketCap":141684339},{"date":"2025-08-22","current":9.896333,"twenty":-29.650007,"median":4.964524,"eighty":10.343658,"marketCap":141684339},{"date":"2025-08-29","current":9.773,"twenty":-29.572253,"median":4.976164,"eighty":10.352561,"marketCap":140911515},{"date":"2025-09-05","current":9.771823,"twenty":-29.518953,"median":4.998145,"eighty":10.331179,"marketCap":140653907},{"date":"2025-09-12","current":10.514775,"twenty":-29.335278,"median":5.052771,"eighty":10.365128,"marketCap":151849546},{"date":"2025-09-16","current":10.874442,"twenty":-29.207499,"median":5.067949,"eighty":10.376926,"marketCap":157140812}],"updateTime":1758111665637},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1170998654","title":"Stock Index Futures Rally Across the Board as Discount Convergence Signals Market Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=1170998654","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170998654?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:33","pubTimestamp":1756128785,"startTime":"0","endTime":"0","summary":"Stock index futures discounts converged significantly, with main contracts transitioning from discount to premium On August 25th, A-shares continued their strong performance with all three major...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","BK4563","399006","159967","159982","510300","000688.SH","512510","IH","000300.SH","512880","000001.SH","399300","510880","000905.SH","515890","399001","BK4085"],"gpt_icon":0},{"id":"2558649458","title":"Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649458","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649458?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996400,"startTime":"0","endTime":"0","summary":"Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/12/3131564/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-and-Business-Highlights-for-the-Second-Quarter-of-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4510","BK4547","AAN","BK4103","BK4563","BK4220","KSS","BK4178","IH","BK4085"],"gpt_icon":0},{"id":"2554767666","title":"Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo","url":"https://stock-news.laohu8.com/highlight/detail?id=2554767666","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554767666?lang=en_us&edition=fundamental","pubTime":"2025-07-25 19:30","pubTimestamp":1753443000,"startTime":"0","endTime":"0","summary":"NEW YORK and MELBOURNE, Australia, July  25, 2025  (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/25/3121737/0/en/Incannex-Healthcare-Expands-Clinical-Advisory-Board-to-Support-Obstructive-Sleep-Apnea-Program-with-Appointment-of-Dr-Charlene-E-Gamaldo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4085","BK4137","HCSG","IH","BK4510"],"gpt_icon":0},{"id":"1148511763","title":"Stock Track | iHuman (IH) Soars 5.04% on Strong Q1 Results and Expanded Educational Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=1148511763","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148511763?lang=en_us&edition=fundamental","pubTime":"2025-06-26 21:42","pubTimestamp":1750945378,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc.  surged 5.04% in pre-market trading on Thursday following the release of its first quarter 2025 unaudited financial results and the announcement of expanded educational offerings. The leading provider of tech-powered, intellectual development products in China continues to show resilience and growth despite challenging market conditions.The company reported Q1 revenues of RMB210.4 million , achieving its 13th consecutive quarter of profitability. While this represents a sli","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"2546789462","title":"iHuman Q1 Adj. EPS $0.07 Up From $0.06 YoY, Sales $28.999M Down From $32.548M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2546789462","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546789462?lang=en_us&edition=fundamental","pubTime":"2025-06-26 18:15","pubTimestamp":1750932911,"startTime":"0","endTime":"0","summary":"iHuman Q1 Adj. EPS $0.07 Up From $0.06 YoY, Sales $28.999M Down From $32.548M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/06/46111061/ihuman-q1-adj-eps-0-07-up-from-0-06-yoy-sales-28-999m-down-from-32-548m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH"],"gpt_icon":0},{"id":"2546978949","title":"BRIEF-Ihuman Q1 Revenue RMB 210.4 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2546978949","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546978949?lang=en_us&edition=fundamental","pubTime":"2025-06-26 18:15","pubTimestamp":1750932910,"startTime":"0","endTime":"0","summary":"BRIEF-Ihuman Q1 Revenue RMB 210.4 MLNJune 26 (Reuters) - Ihuman Inc IH.N:IHUMAN Q1 GROSS PROFIT RMB 143.8 MILLIONIHUMAN Q1 OPERATING EXPENSES RMB 122.2 MILLIONIHUMAN Q1 GROSS MARGIN 68.3%IHUMAN Q1 REV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nPLX1259CF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH"],"gpt_icon":0},{"id":"2546899837","title":"iHuman Inc. Reports Q1 2025 Revenue Decline to RMB210.4 Million, Net Income Rises to RMB26.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2546899837","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546899837?lang=en_us&edition=fundamental","pubTime":"2025-06-26 18:12","pubTimestamp":1750932748,"startTime":"0","endTime":"0","summary":"iHuman Inc. , a leading provider of tech-powered intellectual development products in China, has announced its unaudited financial results for the first quarter ended March 31, 2025. The company reported revenues of RMB210.4 million , a decrease from RMB235.0 million in the same period last year. Gross profit for the quarter was RMB143.8 million , down from RMB168.1 million in the previous year. Despite the decline in revenue and gross profit, iHuman Inc. saw an increase in operating income, which reached RMB21.6 million , compared to RMB17.5 million in the same period last year. Net income also rose to RMB26.5 million  from RMB22.3 million a year ago. The average total monthly active users  for the first quarter were 26.51 million, slightly up from 26.38 million in the same period last year. The company did not provide specific outlook or guidance in the current document.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL3Ld8l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"iHuman Inc. Reports Q1 2025 Revenue Decline to RMB210.4 Million, Net Income Rises to RMB26.5 Million","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH"],"gpt_icon":0},{"id":"2545819712","title":"Press Release: Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch","url":"https://stock-news.laohu8.com/highlight/detail?id=2545819712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545819712?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:30","pubTimestamp":1750764600,"startTime":"0","endTime":"0","summary":"NEW YORK and MELBOURNE, Australia, June 24, 2025  -- Incannex Healthcare Inc.  , a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces the appointment of Douglas B. Kirsch, M.D., FAAN, FAASM to its IHL-42X Obstructive Sleep Apnea  Clinical Advisory Board.\"We are honored to welcome Dr. Kirsch to the IHL-42X Clinical Advisory Board,\" stated Dr. Lou Barbato, Incannex Chief Medical Officer. \"His extensive clinical experience and leadership within the sleep medicine community will be instrumental as we advance IHL-42X through late-stage development. With his addition, our advisory board continues to strengthen its depth of expertise at a pivotal time for the program.\". Designed to act synergistically, IHL-42X uniquely targets two physiological pathways associated with the intermittent hypoxia  and hypercapnia that characterize OSA. In a prior Australian Phase 2 clinical trial, IHL-42X was shown to reduce the Apnea-Hypopnea Ind","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","BK4007","BK4137","IH","HCSG","IXHL","BK4563","BK4085"],"gpt_icon":0},{"id":"2540293776","title":"Press Release: Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2540293776","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540293776?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:30","pubTimestamp":1748950200,"startTime":"0","endTime":"0","summary":"NEW YORK and MELBOURNE, Australia, June 03, 2025  -- Incannex Healthcare Inc.  , a clinical-stage biopharmaceutical company leading the way in developing oral combination medicines, today announced the recent appointment of four distinguished experts to its IHL-42X Obstructive Sleep Apnea  Clinical Advisory Board:. -- Scott A. Sands, Ph.D., Associate Professor of Medicine at Harvard Medical. School and Director of the Sleep Apnea Translational Physiology Group in. the Division of Sleep and Circadian Disorders at Brigham and Women's. Ali Azarbarzin, Ph.D., is an Associate Professor of Medicine at Harvard Medical School and a lead investigator at Brigham and Women's Hospital, where he directs the Sleep Apnea Health Outcomes Group. His research centers on the physiological consequences of sleep apnea, with a focus on identifying markers of cardiovascular and neurocognitive health. Dr. Azarbarzin is also recognized for his wor","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXHL","BK4085","HCSG","BK4007","BK4137","BK4563","IH","BK4510"],"gpt_icon":0},{"id":"2535844440","title":"Press Release: Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535844440","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535844440?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:00","pubTimestamp":1747310400,"startTime":"0","endTime":"0","summary":"NEW YORK and MELBOURNE, Australia, May 15, 2025  -- Incannex Healthcare Inc. , , a clinical-stage biopharmaceutical company leading the way in developing oral combination medicines, today reported fiscal second quarter financial results and provided business highlights for the quarter ended March 31, 2025.\"The third quarter of 2025 represents a pivotal period of progress for Incannex as we continue to execute on our IHL-42X development program,\" said Joel Latham, President and CEO of Incannex. \"With the rapid completion of Phase 2 enrollment in the Phase 2/3 RePOSA, recent positive and confirmatory PK and safety clinical results, and the addition of expert sleep medicine clinical advisory leadership, we are well-positioned to deliver on key upcoming milestones and to advance IHL-42X as a potential treatment for millions of underserved patients living with OSA.\". -- Secured $12.5 million USD in private placement funding, priced. IHL-42X Phase 2/3 obstructive sleep apnea  clinical progra","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"7883e66982e9acef8ce1e1806ddb8b43","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4218","BK4167","BK4007","BK4097","IH","AHI","HCSG","PK","BK4085","BK4563","BK4510","BK4137","IXHL"],"gpt_icon":1},{"id":"2535042289","title":"Press Release: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535042289","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535042289?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220400,"startTime":"0","endTime":"0","summary":"-- Advancing a broad, potential best-in-class orexin receptor 2 . agonist franchise, with key data readouts expected this year. -- ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy. type 1 , narcolepsy type 2  and idiopathic hypersomnia.  on track with data expected across all three indications this. -- ORX142 on track to initiate first-in-human studies for the. clinical data in acutely sleep-deprived healthy volunteers planned. BOSTON and LONDON, May 14, 2025  -- Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company, today reported financial results and business highlights for the first quarter ended March 31, 2025.Dr. Saha continued, \"We are excited to be at the forefront of developing OX2R agonists starting with ORX750, our most advanced OX2R agonist for the treatment of NT1, NT2 and IH. ORX750 is progressing in the Phase 2a CRYSTAL-1 study and is on track with patient data expected across all three indications this year. Given the unmet patient need f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4103","BK4178","PK","BK4535","BK4085","BK4539","BK4139","BK4563","NSS","BK4181","R","BK4218","BK4220","BK4215","KSS","AAN","BK4232","BK4597","ESS","CNTA","BK4510","BK4547","BK4022","IH","BK4588"],"gpt_icon":0},{"id":"2524253635","title":"Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253635","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253635?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:30","pubTimestamp":1743679800,"startTime":"0","endTime":"0","summary":"Topline Phase 2 clinical data expected in the first half 2025NEW YORK and MELBOURNE, Australia, April  03, 2025  (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-sta","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/03/3055022/0/en/Incannex-Healthcare-Completes-Phase-2-Enrollment-in-RePOSA-Phase-2-3-Trial-of-IHL-42X-an-Oral-Once-Daily-Treatment-for-Obstructive-Sleep-Apnea-OSA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4563","BK4510","BK4218","IH","BK4097","BK4181","HCSG","AHI","BK4137","BK4167","BK4085"],"gpt_icon":0},{"id":"1140767178","title":"Stock Track | iHuman Stock Plummets 5.79% Following Disappointing Q4 and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1140767178","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140767178?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:59","pubTimestamp":1742918347,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc. $$ plunged 5.79% in Tuesday's trading session after the Chinese educational technology company reported weaker-than-expected financial results for the fourth quarter and full year of 2024.The Beijing-based firm, which provides tech-powered intellectual development products, saw its revenue decline 7.1% year-over-year to RMB232.7 million  in the fourth quarter. Net income for the quarter fell to RMB26.5 million , compared to RMB33.3 million in the same period last year. The ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"1113014243","title":"Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1113014243","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113014243?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:58","pubTimestamp":1742918333,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc.  plummeted 5.79% in intraday trading on Tuesday after the company reported declines in revenue and profit for the fourth quarter of 2024. The Chinese provider of tech-powered intellectual development products saw its financial performance impacted by demographic trends and cautious consumer spending.iHuman's fourth-quarter revenue fell 7.1% year-over-year to RMB232.7 million , down from RMB250.4 million in the same period last year. The company attributed this decline to Ch","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"2522609170","title":"Press Release: iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522609170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522609170?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:03","pubTimestamp":1742889780,"startTime":"0","endTime":"0","summary":"BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc.  , a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.-- Revenues were RMB232.7 million , compared with RMB250.4. RMB178.2 million in the same period last year.RMB21.9 million in the same period last year.-- Net income was RMB26.5 million , compared with RMB33.3. -- Average total MAUs[1] for the fourth quarter were 25.78 million, compared. At the heart of our success is our long-standing dedication to technological innovation, particularly in artificial intelligence. Since establishing our AI Lab in 2018, we have consistently invested in cutting-edge advancements and seamlessly integrated them into our product offerings. By embracing transformative technologies such as AI-generated content , we became one of the first companies in China to develop and launch a proprietary large language model , a ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH","BK4085","BK4510","BK4563"],"gpt_icon":0},{"id":"2521745072","title":"Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745072","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745072?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024. -- Advancing a broad, potential best-in-class orexin receptor 2 . agonist franchise with key data readouts expected in 2025. -- ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy. type 1 , narcolepsy type 2  and idiopathic hypersomnia.  well underway and on track with data expected across all. three indications in 2025 with first-in-class potential in NT2 and. Dr. Saha concluded, \"In addition to the transformational potential of ORX750 for individuals living with sleep-wake disorders, we see tremendous opportunity with our follow-up OX2R agonists that are being advanced for the treatment of EDS, impaired attention, cognitive deficits and fatigue in neurological, neurodegenerative and neuropsychiatric disorders. ORX142 is prog","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","IH","BK4022","BK4585","BK4535","AAN","BK4539","ESS","BK4510","PK","BK4232","BK4218","BK4215","BK4588","NSS","MSL","BK4085","BK4139","BK4597","BK4178","BK4181","BK4563","CNTA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}